Cited by 411Computational Drug Discovery MethodsMachine Learning in Materials ScienceHistory and advancements in chemistry

Application of Generative Autoencoder in De Novo Molecular Design

Open access
Blaschke, Thomas, Olivecrona, Marcus, Engkvist, Ola, Bajorath, Jürgen, Chen, Hongming·2018·Molecular Informatics

Abstract

A major challenge in computational chemistry is the generation of novel molecular structures with desirable pharmacological and physiochemical properties. In this work, we investigate the potential use of autoencoder, a deep learning methodology, for de novo molecular design. Various generative autoencoders were used to map molecule structures into a continuous latent space and vice versa and their performance as structure generator was assessed. Our results show that the latent space preserves chemical similarity principle and thus can be used for the generation of analogue structures. Furthermore, the latent space created by autoencoders were searched systematically to generate novel compounds with predicted activity against dopamine receptor type 2 and compounds similar to known active compounds not included in the trainings set were identified.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/minf.201700123

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Blaschke et al. applied adversarial autoencoders and Bayesian optimization to generate ligands specific to the dopamine type 2 receptor.

    “Blaschke et al. also applied adversarial autoencoders and Bayesian optimization to generate ligands specific to the dopamine type 2 receptor [22].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 19 · Cited by 411

Research works printed but not linked: 8

  1. [12]R. Gómez-Bombarelli, D. Duvenaud, J. M. Hernández-Lobato, J. Aguilera-Iparraguirre, T. D. Hirzel, R. P. Adams, A. Aspuru-Guzik, ArXiv:1610.02415 Phys. 2016. · arXiv
  2. [15]H. Abdi, L. J. Williams, Wiley Interdiscip. Rev. Comput. Stat. 2010, 2, 433– 459.
  3. [18]I. Goodfellow, Y. Bengio, A. Courville, Deep Learning, MIT Press, 2016.
  4. [21]T. Lei, R. Barzilay, T. Jaakkola, ArXiv:1508.04112 Cs 2015. · arXiv
  5. [22]P. Y. Simard, D. Steinkraus, J. C. Platt, in Proc. Seventh Int. Conf. Doc. Anal. Recognit. – Vol. 2, IEEE Computer Society, Washington, DC, USA, 2003, 958.
  6. [26]R. J. Williams, D. Zipser, Neural Comput. 1989, 1, 270– 280.
  7. [30]C. E. Rasmussen, C. K. I. Williams, Gaussian Processes for Machine Learning (Adaptive Computation and Machine Learning), The MIT Press, 2005.
  8. [31]D. R. Jones, M. Schonlau, W. J. Welch, J. Glob. Optim. 1998, 13, 455– 492.

Authors
Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J., & Chen, H.
Affiliations
  • University of Bonn (DE)
  • AstraZeneca (Sweden) (SE)
Corresponding author
  • Blaschke, Thomas
  • Chen, Hongming
Venue
Molecular Informatics
Publisher
Wiley
Published
2017-12-13
Volume
37
Issue
1-2
ISSN
  • 1868-1743 (ISSN-L)
  • 1868-1751
OpenAlex
W2963445908
Cited by
411
References
19
Citations by year
2026: 16 · 2025: 26 · 2024: 38 · 2023: 50 · 2022: 53 · 2021: 91 · 2020: 65 · 2019: 42 · 2018: 28 · 2017: 2
FWCI
28.11
Type
journal article
Language
en
Open access
Locations
  • Molecular Informatics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • arXiv (Cornell University) (submittedVersion)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
  • arXiv (Cornell University)
Funders
European Union's Horizon 2020 research and innovation program (676434)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Physical Sciences › Chemistry › Physical and Theoretical Chemistry › History and advancements in chemistry
Keywords
generative autoencoders, de novo molecular design, latent space, molecular similarity, structure-activity relationship
MeSH terms
Deep Learning, Drug Design, Quantitative Structure-Activity Relationship

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review